Resources

Elevated BP readings at the doctor’s office linked to higher mortality than for those with consistently normal blood pressure.

Use of expanded criteria thought best way to detect widest population with abnormal blood glucose levels.

It can improve insulin sensitivity, pancreatic response to blood sugars, and even prevent prediabetes from turning into diabetes.

ADA Guidelines highlight importance of social stability in diabetes management.

After four years of good glycemic control with metformin 1500 mg a day, Mrs. Hunter returns for her 6-month follow-up visit. At this time, her office A1C is 8.2% and she has gained seven pounds. She is very concerned about her weight gain. If weight is a concern, what would be the best antiglycemic drug to add to her regimen? A. A sulfonylurea B. A DPP-4 inhibitor C. A thiazolidinedione D. A GLP-1 receptor agonist Follow the link for the answer.

Are you seeing more children with type 2 diabetes in your practice? Follow the link to share your response.

We all know the benefits of the newer insulins, i.e., faster action times, less peak from the long actings, etc. But the cost, more often than we know, can lead to patients decreasing insulin doses, doing without until the next payday, or doing without it altogether, as we’ve read about. …

In this week's Homerun Slides, we begin to take a look at how the structure of technology's use in outpatient care. Dr. Stanley Schwartz discusses how this might benefit the management of diabetes.

Incretin defect: Oral glucose elicits a greater insulin response than does intravenous glucose. As first demonstrated by Nauck et al., when tested at matched plasma glucose concentrations (iso- glycemic protocol) the oral route of glucose administration induces a robust increment in insulin secretion as compared with the intravenous route. In nondiabetic subjects, such potentiation — named incretin effect — averages 50 – 70% with a standard (75 g) oral glucose load, and increases with the size of the glucose load. As depicted in Figure 24.10, the incretin effect is characteristically lost in patients with T2DM.

Several population studies have demonstrated that when people are diagnosed with type 2 diabetes earlier in life, the risk of earlier complications including mortality related to the diabetes is significantly higher than in older populations.